Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,129 public trials 394 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects

NCT01593046

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Daytona Beach, Florida, United States
  • GSK Investigational Site Overland Park, Kansas, United States
View Trial Details
Completed

Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)

NCT00552240

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • 1100.1512.28 Boehringer Ingelheim Investigational Site Beverly Hills, California, United States
  • 1100.1512.20 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
  • 1100.1512.15 Boehringer Ingelheim Investigational Site Denver, Colorado, United States
  • 1100.1512.26 Boehringer Ingelheim Investigational Site Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Completed

Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults

NCT00389207

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • 1100.1470.54004 Boehringer Ingelheim Investigational Site Capital Federal, Argentina
  • 1100.1470.54002 Boehringer Ingelheim Investigational Site Córdoba, Argentina
  • 1100.1470.54003 Boehringer Ingelheim Investigational Site Mar del Plata, Argentina
  • 1100.1470.54001 Boehringer Ingelheim Investigational Site Rosario, Argentina
View all 68 locations
View Trial Details
Completed

A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1

NCT00824421

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Pfizer Investigational Site Buenos Aires, Argentina
  • Pfizer Investigational Site Darlinghurst, New South Wales, Australia
  • Pfizer Investigational Site Melbourne, Victoria, Australia
  • Pfizer Investigational Site Toronto, Ontario, Canada
View all 31 locations
View Trial Details
Completed

Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection.

NCT00849160

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Centre Hospitalier Universitaire de Bicêtre - Service de Médecine Interne et Maladies Tropicales Le Kremlin-Bicêtre, France
  • Groupe Hospitalier Pitié-Salpêtrière - Service de Médecine Interne Paris, France
  • Groupe Hospitalier Pitié-Salpêtrière - Service des Maladies Infectieuses et Tropicales Paris, France
  • Hôpital Necker Enfants Malades - Service des Maladies Infectieuses et Tropicales Paris, France
View Trial Details
Completed

Comparison of HIV Testing Algorithms

NCT01716299

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Abdurafi Health Center Ābderafī, Amhara Regional State, Ethiopia
  • Humera Hospital Humera, Tigray, Ethiopia
View Trial Details

Related conditions